clinical trial · NCT07133399
A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood
Boehringer Ingelheim·phase1·completed·n = 32
Healthyvicadrostat / empagliflozin combination 1vicadrostat / empagliflozin 2
brief summary
To investigate the relative bioavailability of two different vicadrostat/empagliflozin combinations. Additionally, the trial investigates the effect of food on the pharmacokinetics of the vicadrostat/empagliflozin.
started
Sep 8, 2025
primary completion
Oct 22, 2025
completion
Oct 22, 2025
last updated
Jan 6, 2026
official title
Relative Bioavailability of Two Different Vicadrostat/ Empagliflozin Combinations and Investigation of the Effect of Food on the Pharmacokinetics of a Vicadrostat/ Empagliflozin Combination in Healthy Male and Female Volunteers (an Open-label, Randomised, Single-dose, Three- Way Crossover Study)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol